India's Richest People 2026 edition · 2 directors · Source: Hurun India
- #1,202 M Narayana Reddy & family ₹2,000 Cr
- #1,427 LV Subba Reddy & family ₹1,500 Cr
Revenue · FY 2025
₹185.43 Cr
▼ 6% YoY
Net profit · FY 2025
₹81.13 Cr
Net margin 43.8%
EBITDA · FY 2025
₹108.25 Cr
EBITDA margin 58.4%
Authorised capital
₹32.5 Cr
Registered with MCA
Paid-up capital
₹12.24 Cr
Issued & subscribed
Open charges
₹12.41 Cr
Secured borrowings
Company age
22 yrs
Est. 2004
Employees · EPFO
107
Provident fund records
About Virchow Drugs Limited
Data last updated:
Virchow Drugs Limited is a public limited company based in Hyderabad, Telangana, India, a subsidiary of Virchow Laboratories Limited. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 25 March 2004 and has been in existence for over 22 years.
Its director M Narayana Reddy and family are #1,202 among India's richest people (2026). Its director LV Subba Reddy and family are #1,427 among India's richest people (2026).
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2004PLC042949. Its GSTIN is 36AABCV8335K1ZY (Telangana). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹32.5 Cr and a paid-up capital of ₹12.24 Cr. It was formerly known as Virchow Drugs Private Limited. It is led by directors including Pamidi Ravindra (Whole-Time Director) and Lingareddy Subba Reddy Venkata.
Its last annual general meeting (AGM) was held on 27 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No.9 S.V. Co – Op Indl Estate Ida Jeedimetla, Hyderabad, Telangana, India – 500055.
As per the financials filed for FY 2025, the company reported a revenue of ₹185.43 Cr, a decline of 6% compared to the previous year. For the same year it recorded a net profit of ₹81.13 Cr (net margin 43.8%) and EBITDA of ₹108.25 Cr (EBITDA margin 58.4%). Revenue has declined at a compounded annual rate (CAGR) of 8% over three years and 1% over five years.
The company has about 107 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹12.41 Cr on record. Court records list 7 cases involving the company, including 6 filed by the company and 1 filed against it; 2 cases are pending. The company has 9 deals on record (8 secondary share transfers, 1 funding round), with disclosed funding of ₹8.33 Cr; the latest was in March 2021. Its 9 peer companies in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 5 larger and 4 smaller; the largest is Vindhya Organics Private Limited with revenue of ₹193.92 Cr.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website virchows.com.
Company details
CIN U24239TG2004PLC042949
Registration Number 042949
Incorporation Date 25 March 2004
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Parent Company Virchow Laboratories Limited
Compliance Status Active Compliant
CIN history
Virchow Drugs has one previous CIN (Corporate Identification Number): U24239AP2004PLC042949. The current CIN is U24239TG2004PLC042949, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239TG2004PLC042949 | Current |
| U24239AP2004PLC042949 | Previous |
Key People
Pamidi Ravindra Whole-Time Director Lingareddy Subba Reddy Venkata Director Prasanth Nandigala Director Recognitions & Rankings of Virchow Drugs
Contact details
Virchow Drugs Limited's registered office is in Hyderabad, Telangana. Its website is virchows.com. Its e-mail address is in the company report.
- Email
- Website
- Social Media
- Registered AddressPlot No.9 S.V. Co – Op Indl Estate Ida Jeedimetla, Hyderabad, Telangana, India – 500055
- IndustryPharma, API Manufacturers
To see the full contact details of Virchow Drugs Limited, buy the company report.
Comprehensive company report
Virchow Drugs Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Virchow Drugs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Virchow Drugs Limited, buy the company report.
Financials of Virchow Drugs Limited
FY 2025 filings availableVirchow Drugs Limited reported revenue of ₹185.43 Cr (down 6% YoY) for FY 2025.
Revenue · FY 2025
₹185.43 Cr ▼ 6%
Net profit · FY 2025
₹81.13 Cr margin 43.8%
EBITDA · FY 2025
₹108.25 Cr margin 58.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 6%
3 years · compounded
▼ 8%
5 years · compounded
▼ 1%
EBITDA CAGR growth
1 year
▲ 109%
3 years · compounded
▲ 27%
5 years · compounded
▲ 16%
Revenue has declined at a compounded annual rate (CAGR) of 1% over five years, including a 6% fall in the latest year. EBITDA rose 109% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹108.25 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹81.13 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 58.4% | ||||
| Net Profit Margin | 43.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Virchow Drugs Limited, buy the company report.
Board of directors of Virchow Drugs Limited
Virchow Drugs has 8 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Lingareddy Subba Reddy Venkata Also directs: Virchow Petrochemical Private Limited, Virchow Laboratories Limited, Anand Mines Products Private Limited and 5 more | Director | 31 Mar 2009 | 17 Years 7 Months | Current |
| Prasanth Nandigala Also directs: Virchow Petrochemical Private Limited, Andhra Organics Limited, Virchow Laboratories Limited and 5 more | Director | 12 Sep 2007 | 19 Years 2 Months | Current |
| Pamidi Ravindra | Whole-Time Director | 24 Dec 2020 | 5 Years 10 Months | Current |
| Sudha Mundla Also directs: Virchow Petrochemical Private Limited, Andhra Organics Limited, Virchow Laboratories Limited and 1 more | Director | 31 Mar 2009 | 17 Years 7 Months | Current |
| Narayana Reddy Mundla Also directs: Virchow Petrochemical Private Limited, Andhra Organics Limited, Virchow Laboratories Limited and 2 more | Director | 25 Mar 2004 | 22 Years 7 Months | Current |
| Nauroji Reddy Alla Also directs: Virchow Laboratories Limited | Director | 02 Jun 2025 | 1 Years 5 Months | Current |
Showing 6 of 8 current directors. View all directors
Peer comparison
Virchow Drugs Limited is compared with the 9 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vindhya Organics Private Limited | ₹193.92 Cr (FY 2025) | 4.0% | Bollaram, Telangana, India | |||
| RV Lifesciences Limited | ₹192.9 Cr (FY 2025) | 249.0% | Aurangabad, Maharashtra, India | |||
| Malwa Oxygen & Industrial Gases Private Limited | ₹192.64 Cr (FY 2025) | 9.0% | Ratlam, Madhya Pradesh, India | |||
| Shree Jaya Laboratories Private Limited | ₹186.81 Cr (FY 2025) | -9.0% | Telangana, India | |||
| Multi Organics Private Limited | ₹185.7 Cr (FY 2025) | 2.0% | Mumbai, Maharashtra, India | |||
| Virchow Drugs Limitedthis company | ₹185.43 Cr (FY 2025) | ₹81.13 Cr | 43.8% | -6.0% | 107 | Hyderabad, Telangana, India |
| GMFC Labs Private Limited | ₹179.23 Cr (FY 2025) | 106.0% | Hyderabad, Telangana, India | |||
| Chandak Laboratories Private Limited | ₹178.82 Cr (FY 2024) | -26.0% | Hyderabad, Telangana, India | |||
| Mahima Lifesciences Private Limited | ₹177.98 Cr (FY 2025) | -18.0% | Delhi, India | |||
| Elppe Chemicals Private Limited | ₹173.94 Cr (FY 2024) | 8.0% | Raigad, Maharashtra, India |
To see the full peer comparison of Virchow Drugs Limited, buy the company report.
Auditor
Virchow Drugs Limited is audited by Suryanarayana Reddy & Co for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Suryanarayana Reddy & Co | FY 2023 | 005752S |
Shareholding
The shareholding of Virchow Drugs Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Virchow Drugs Limited, buy the company report.
Charges & borrowings
Open charges
₹12.41 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 22 Sep 2005 | 80043611 | Canara Bank | ₹12.41 Cr | Open |
To see the full charge records of Virchow Drugs Limited, buy the company report.
Total charge records: 1 View all charges
Deals & funding
Virchow Drugs Limited has 9 deals on record (8 secondary share transfers, 1 funding round), with disclosed funding of ₹8.33 Cr; the latest was in March 2021.
Total deals
9
Secondary share transfers
8
Funding round
1
Disclosed funding
₹8.33 Cr
Deals on record (5 of 9)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2021 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2020 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Apr 2016 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Jan 2015 | Secondary share transfer | Undisclosed | Seller: Virchow Laboratories Limited , 3 individuals |
| Mar 2009 | Secondary share transfer | Undisclosed | Buyer: Virchow Laboratories Limited Seller: Ciba Specialty Chemicals India Limited |
To see the full deal history of Virchow Drugs Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Virchow Drugs Limited has 7 court cases on record: 6 filed by Virchow Drugs, 1 filed against it. 2 cases are pending and 5 are disposed.
Total cases
7
Filed by the company
6
Filed against the company
1
Pending
2
Disposed
5
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 7 | 1 | 2 |
Cases on record (5 of 7)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, ANDHRAPRADESH | Writ petition | Filed by the company against Eastern Power Distribution Company of Andhra Pradesh Ltd. and 2 others | Disposed |
| High Court, TELANGANA | Writ petition | Filed by the company against Eastern Power Distribution Company of Andhra Pradesh Ltd and 8 others | Disposed |
| High Court, TELANGANA | Writ petition | Filed by the company against Central Power Distribution Company of Andhra Pradesh Ltd., and 8 others | Disposed |
| High Court, TELANGANA | Appeal | Filed by the company against Central Power Distribution Company of Andhra Pradesh Ltd. and 9 others | Disposed |
| High Court, TELANGANA | Appeal | Filed against the company by individuals | Pending |
To see the full case history of Virchow Drugs Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Virchow Drugs Limited was last rated by Icra on 24 Jan 2021.
| Rating agency | Rated on | Rating |
|---|---|---|
| Icra | 24 Jan 2021 |
To see the full credit ratings and regulatory alerts of Virchow Drugs Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Virchow Drugs Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Virchow Drugs Limited has a workforce of 107 employees on its EPFO records as of May 2026, across 2 active EPFO establishments.
Employee count
107
Active EPFO establishments
2
Employee growth
0.9%
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 107 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Virchow Drugs Limited, buy the company report.
GST
Virchow Drugs has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AABCV8335K1ZY | Telangana | Active | 01 Jul 2017 |
| 37AABCV8335K1ZW | Andhra Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Virchow Drugs Limited, buy the company report.
Recent activity
Virchow Drugs Limited has 24 board changes on record since 2004: 16 appointments and 8 cessations. The latest: Nauroji Reddy Alla was appointed as Director on 02 Jun 2025.
AGM
Virchow Drugs Limited last Annual general meeting of members was held on 27 Sep 2025 as per latest MCA records.
Appointed
Nauroji Reddy Alla was appointed as Director.
Appointed
Ramakrishna Reddy Kona was appointed as Director.
Filing
Virchow Drugs Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Ceased
Ravindra Reddy Venga Reddy Kutagulla ceased to be Director.
Ceased
Venkata Reddy Alla ceased to be Director.
Appointed
Abhinav Reddy Nandigala was appointed as Director.
Ceased
Venkata Reddy Nandigala ceased to be Director.
Appointed
Pamidi Ravindra was appointed as Whole-Time Director.
Ceased
Hari Mohan Reddy Kamidi ceased to be Whole-Time Director.
Appointed
Ravindra Reddy Venga Reddy Kutagulla was appointed as Director.
Appointed
Venkata Reddy Alla was appointed as Director.
17 earlier events are in the company report.
Frequently asked questions
Virchow Drugs is an active public limited company based in Hyderabad, Telangana, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 25 March 2004 (22+ years old) and is registered under CIN U24239TG2004PLC042949.
Virchow Drugs has 8 current directors:
- Pamidi Ravindra - Whole-Time Director
- Lingareddy Subba Reddy Venkata - Director
- Prasanth Nandigala - Director
- Sudha Mundla - Director
- Narayana Reddy Mundla - Director
- Nauroji Reddy Alla - Director
- Ramakrishna Reddy Kona - Director
- Abhinav Reddy Nandigala - Director
The latest financial statements of Virchow Drugs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 27 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Virchow Drugs is 36AABCV8335K1ZY, registered in Telangana. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 37AABCV8335K1ZW (Andhra Pradesh).
The CIN (Corporate Identification Number) of Virchow Drugs is U24239TG2004PLC042949. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Virchow Drugs has 7 court cases on record: 6 filed by the company and 1 filed against it. 2 are pending.
Virchow Drugs was incorporated on 25 March 2004, making it 22+ years old. It is registered with the Registrar of Companies, Hyderabad.
Virchow Drugs has 9 deals on record (8 secondary share transfers, 1 funding round), with disclosed funding of ₹8.33 Cr; the latest was in March 2021.
The peers of Virchow Drugs by revenue are Vindhya Organics Private Limited, RV Lifesciences Limited, Malwa Oxygen & Industrial Gases Private Limited, Shree Jaya Laboratories Private Limited, Multi Organics Private Limited and 4 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Nauroji Reddy Alla was appointed as Director on 02 Jun 2025. Ramakrishna Reddy Kona was appointed as Director on 02 Jun 2025. Ravindra Reddy Venga Reddy Kutagulla ceased to be Director on 20 Mar 2025. Virchow Drugs has 24 board changes on record in total.
Virchow Drugs can be reached through the website virchows.com. Its registered office is in Hyderabad, Telangana, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages